Search

everythinglearnresearchcommunity

for

Search:↓

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Microneedling may improve quality of life and reduce inflammation in frontal fibrosing alopecia.

Chronic lupus and frontal fibrosing alopecia can occur together, but their connection is unclear.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Two siblings both had a rare case of alopecia areata at the same time.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

FFA has higher long-term remission rates than LPP.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

People with alopecia have a higher risk of thyroid cancer.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.